-
Je něco špatně v tomto záznamu ?
The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism
Z. Minarikova, L. Gaspar, P. Kruzliak, Z. Celecová, S. Oravec,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
BioMedCentral
od 2002-12-01
BioMedCentral Open Access
od 2002
Directory of Open Access Journals
od 2002
Free Medical Journals
od 2002
PubMed Central
od 2002
Europe PubMed Central
od 2002
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2002-01-01
Open Access Digital Library
od 2002-09-01
Open Access Digital Library
od 2002-01-01
Medline Complete (EBSCOhost)
od 2002-09-03
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2002
Springer Nature OA/Free Journals
od 2002-12-01
PubMed
25300222
DOI
10.1186/1476-511x-13-158
Knihovny.cz E-zdroje
- MeSH
- apolipoprotein A-I krev izolace a purifikace MeSH
- apolipoprotein B-100 krev izolace a purifikace MeSH
- dospělí MeSH
- elektroforéza v polyakrylamidovém gelu MeSH
- Hashimotova nemoc krev farmakoterapie MeSH
- hypertyreóza krev farmakoterapie MeSH
- LDL-cholesterol krev izolace a purifikace MeSH
- lidé středního věku MeSH
- lidé MeSH
- lipoproteiny VLDL krev izolace a purifikace MeSH
- methimazol terapeutické užití MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- thyreostatika terapeutické užití MeSH
- thyroxin terapeutické užití MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Atherogenic dyslipoproteinemia is one of the most important risk factor for atherosclerotic changes development. Hypothyroidism is one of the most common causes of secondary dyslipidemias which results from reduced LDL clearance and therefore raised levels of LDL and apoB. Association between small dense LDL (sdLDL) presentation and thyroid status has been examinated using polyacrylamide gel electrophoresis for lipoprotein subfractions evaluation. METHODS: 40 patients with diagnosed autoimmune hypothyroidism and 30 patients with autoimmune hyperthyroidism were treated with thyroxine replacement or thyreo-suppressive treatment. In both groups lipid profiles, LDL subractions, apolipoproteins (apoA1, apoB), apoA1/apoB ratio and atherogenic index of plazma (AIP) were examined before treatment and in state of euthyreosis. RESULTS: Thyroxine replacement therapy significantly reduced levels of total cholesterol (TC), LDL, triglycerides (TG) and also decreased levels of sdLDL (8,55±11,671 vs 0,83±1,693mg/dl; p<0,001), apoB and AIP. For estimation of atherogenic lipoprotein profile existence an AIP evaluation seems to be better than apoB measurement because of the more evident relationship with sdLDL (r=0,538; p<0,01). Thyreo-suppressive therapy significantly increased levels of TC, LDL, TG and apoB. The sdLDL was not found in hyperthyroid patients. CONCLUSIONS: Atherogenic lipoprotein profile was present in 52.5% of hypothyroid subjects, which is higher prevalence than in normal, age-related population. Substitution treatment leads to an improvement of the lipid levels, TG, apoB, AIP and LDL subclasses. It significantly changed the presentation of sdLDL - we noticed shift to large, less atherogenic LDL particles. Significantly positive correlation between sdLDL and TAG; sdLDL and VLDL alerts to hypertriglyceridemia as a major cardiovascular risk factor.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15014028
- 003
- CZ-PrNML
- 005
- 20150428105250.0
- 007
- ta
- 008
- 150420s2014 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/1476-511X-13-158 $2 doi
- 035 __
- $a (PubMed)25300222
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Minarikova, Zuzana
- 245 14
- $a The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism / $c Z. Minarikova, L. Gaspar, P. Kruzliak, Z. Celecová, S. Oravec,
- 520 9_
- $a BACKGROUND: Atherogenic dyslipoproteinemia is one of the most important risk factor for atherosclerotic changes development. Hypothyroidism is one of the most common causes of secondary dyslipidemias which results from reduced LDL clearance and therefore raised levels of LDL and apoB. Association between small dense LDL (sdLDL) presentation and thyroid status has been examinated using polyacrylamide gel electrophoresis for lipoprotein subfractions evaluation. METHODS: 40 patients with diagnosed autoimmune hypothyroidism and 30 patients with autoimmune hyperthyroidism were treated with thyroxine replacement or thyreo-suppressive treatment. In both groups lipid profiles, LDL subractions, apolipoproteins (apoA1, apoB), apoA1/apoB ratio and atherogenic index of plazma (AIP) were examined before treatment and in state of euthyreosis. RESULTS: Thyroxine replacement therapy significantly reduced levels of total cholesterol (TC), LDL, triglycerides (TG) and also decreased levels of sdLDL (8,55±11,671 vs 0,83±1,693mg/dl; p<0,001), apoB and AIP. For estimation of atherogenic lipoprotein profile existence an AIP evaluation seems to be better than apoB measurement because of the more evident relationship with sdLDL (r=0,538; p<0,01). Thyreo-suppressive therapy significantly increased levels of TC, LDL, TG and apoB. The sdLDL was not found in hyperthyroid patients. CONCLUSIONS: Atherogenic lipoprotein profile was present in 52.5% of hypothyroid subjects, which is higher prevalence than in normal, age-related population. Substitution treatment leads to an improvement of the lipid levels, TG, apoB, AIP and LDL subclasses. It significantly changed the presentation of sdLDL - we noticed shift to large, less atherogenic LDL particles. Significantly positive correlation between sdLDL and TAG; sdLDL and VLDL alerts to hypertriglyceridemia as a major cardiovascular risk factor.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a thyreostatika $x terapeutické užití $7 D013956
- 650 _2
- $a apolipoprotein A-I $x krev $x izolace a purifikace $7 D016632
- 650 _2
- $a apolipoprotein B-100 $x krev $x izolace a purifikace $7 D053299
- 650 _2
- $a LDL-cholesterol $x krev $x izolace a purifikace $7 D008078
- 650 _2
- $a elektroforéza v polyakrylamidovém gelu $7 D004591
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a Hashimotova nemoc $x krev $x farmakoterapie $7 D050031
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypertyreóza $x krev $x farmakoterapie $7 D006980
- 650 _2
- $a lipoproteiny VLDL $x krev $x izolace a purifikace $7 D008079
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a methimazol $x terapeutické užití $7 D008713
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a thyroxin $x terapeutické užití $7 D013974
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Gaspar, Ludovit
- 700 1_
- $a Kruzliak, Peter $u Department of Cardiovascular Diseases, International Clinical Research Center, St, Anne's University Hospital and Masaryk University, Pekarska 53, Brno 656 91, Czech Republic. peter.kruzliak@savba.sk.
- 700 1_
- $a Celecová, Zuzana
- 700 1_
- $a Oravec, Stanislav
- 773 0_
- $w MED00008241 $t Lipids in health and disease $x 1476-511X $g Roč. 13, č. - (2014), s. 158
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25300222 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150420 $b ABA008
- 991 __
- $a 20150428105550 $b ABA008
- 999 __
- $a ok $b bmc $g 1071609 $s 896906
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 13 $c - $d 158 $i 1476-511X $m Lipids in health and disease $n Lipids Health Dis $x MED00008241
- LZP __
- $a Pubmed-20150420